Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Recruiting · NCT02974647 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-09-24 | NCT02974647 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cornell University | 41 |
| Dana-Farber Cancer Institute | 324 |
| Memorial Sloan Kettering Cancer Center | 753 |
| Thomas Jefferson University | 115 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | United States | 189 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Commack | Commack | United States | 189 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | United States | 92 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Uniondale | United States | 53 |
| Memorial Sloan Kettering Westchester | East White Plains | United States | 24 |
| Northwestern Medicine (Data collection and specimen analysis) | Chicago | United States | 1 |
| University of Miami | Miami | United States | 6 |
| Weill Cornell Medical College | New York | United States | 1 |